Ergomed PLC

Ergomed PLC
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
44.86 M
Public Float
-
Ergomed PLC
Stock Exchange London Stock Exchange
EPS
GBP0.2
Market Cap
GBP129.41 M
Shares Outstanding
46.54 M
Public Float
32.44 M

Profile

Address
The Surrey Research Park
Guildford Surrey GU2 7YD
United Kingdom
Employees -
Website http://ergomedplc.com/
Updated 07/08/2019
Ergomed Plc is a clinical development company. The company is engaged in the provision of services to the pharmaceutical industry and the development of orphan drugs. It focuses on the development of oncology, neurology and immunology drugs.

Financials

View All
Created with Highcharts 5.0.14Ergomed PLCNet Income. Fiscal year is January-December. All values GBP Thousands.1 5461 5465785781 5521 55270704 5044 5048 9808 98020132014201520162017201802k4k6k8k10k
Created with Highcharts 5.0.14Ergomed PLCSales/Revenue. Fiscal year is January-December. All values GBP Thousands.15 14715 14721 15521 15530 17830 17839 23339 23347 62447 62454 11254 112201320142015201620172018010k20k30k40k50k60k

Peter Lutz George
Chairman
Stephen A. Stamp
Chief Executive Officer & Director